Girao, E. S. et al. Prevalence of Clostridioides difficile associated diarrhea in hospitalized patients in five Brazilian centers: a multicenter, prospective study. Anaerobe 66, 102267 (2020).
Marra, A. R. et al. Incidence and outcomes associated with Clostridium difficile infections: a systematic review and meta-analysis. JAMA Netw. Open 3, e1917597 (2020).
Jazmati, N. et al. Occurrence and trends of Clostridioides difficile infections in hospitalized patients: a prospective multi-centre cohort study in six German university hospitals, 2016–2020. J. Hosp. Infect. 151, 161–172 (2024).
Viprey, V. F. et al. European survey on the current surveillance practices, management guidelines, treatment pathways and heterogeneity of testing of Clostridioides difficile, 2018–2019: results from the Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI). J. Hosp. Infect. 131, 213–220 (2023).
Kim, J. et al. Incidence of Clostridioides difficile infections in Republic of Korea: a prospective study with active surveillance vs. national data from health insurance review & assessment service. J. Korean Med. Sci. 39, e118 (2024).
Braga, D. S. et al. Incidence of healthcare-associated Clostridioides difficile infection in a quaternary referral university hospital in Brazil. Anaerobe 79, 102672 (2023).
Barlam, T. F. et al. Retrospective analysis of long-term gastrointestinal symptoms after Clostridium difficile infection in a nonelderly cohort. PLoS ONE 13, e0209152 (2018).
Gutierrez, R. L., Riddle, M. S. & Porter, C. K. Increased risk of functional gastrointestinal sequelae after Clostridium difficile infection among active duty United States military personnel (1998–2010). Gastroenterology 149, 1408–1414 (2015).
Costa, D. V. S. et al. Clostridioides difficile infection promotes gastrointestinal dysfunction in human and mice post-acute phase of the disease. Anaerobe 87, 102837 (2024).
Wadhwa, A. et al. High risk of post-infectious irritable bowel syndrome in patients with Clostridium difficile infection. Aliment. Pharmacol. Ther. 44, 576–582 (2016).
Peery, A. F. et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2021. Gastroenterology 162, 621–644 (2022).
Ge, X. et al. Antibiotics-induced depletion of mice microbiota induces changes in host serotonin biosynthesis and intestinal motility. J. Transl. Med. 15, 13 (2017).
Johnson, S. et al. Clinical practice guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of Clostridioides difficile infection in adults. Clin. Infect. Dis. 73, 755–757 (2021).
von Boyen, G. B. et al. Distribution of enteric glia and GDNF during gut inflammation. BMC Gastroenterol. 11, 3 (2011).
Costa, D. V. S. et al. S100B inhibition attenuates intestinal damage and diarrhea severity during Clostridioides difficile infection by modulating inflammatory response. Front. Cell. Infect. Microbiol. 11, 739874 (2021).
Manion, J. et al. C. difficile intoxicates neurons and pericytes to drive neurogenic inflammation. Nature 622, 611–618 (2023).
Santos, A. et al. P2X7 receptor blockade decreases inflammation, apoptosis, and enteric neuron loss during Clostridioides difficile toxin A-induced ileitis in mice. World J. Gastroenterol. 28, 4075–4088 (2022).
Costa, D. V. S. et al. Adenosine receptors differentially mediate enteric glial cell death induced by Clostridioides difficile toxins A and B. Front. Immunol. 13, 956326 (2022).
Zhang, K. et al. TcdB from hypervirulent Clostridioides difficile induces neuronal loss and neurotransmitter alterations in the intrinsic enteric nervous system. J. Infect. Dis. https://doi.org/10.1093/infdis/jiae498 (2024).
Xia, Y., Hu, H. Z., Liu, S., Pothoulakis, C. & Wood, J. D. Clostridium difficile toxin A excites enteric neurones and suppresses sympathetic neurotransmission in the guinea pig. Gut 46, 481–486 (2000).
Mantyh, C. R., McVey, D. C. & Vigna, S. R. Extrinsic surgical denervation inhibits Clostridium difficile toxin A-induced enteritis in rats. Neurosci. Lett. 292, 95–98 (2000).
Pothoulakis, C. et al. CP-96,345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin. Proc. Natl Acad. Sci. USA 91, 947–951 (1994).
Keates, A. C. et al. CGRP upregulation in dorsal root ganglia and ileal mucosa during Clostridium difficile toxin A-induced enteritis. Am. J. Physiol. 274, G196–G202 (1998).
Wen, B. J. et al. Prevalence and molecular characterization of Clostridioides difficile infection in China over the past 5 years: a systematic review and meta-analysis. Int. J. Infect. Dis. 130, 86–93 (2023).
Cui, Y. et al. An epidemiological surveillance study (2021–2022): detection of a high diversity of Clostridioides difficile isolates in one tertiary hospital in Chongqing, Southwest China. BMC Infect. Dis. 23, 703 (2023).
McDonald, L. C. et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin. Infect. Dis. 66, 987–994 (2018).
Costa, D. V. S. et al. Influence of binary toxin gene detection and decreased susceptibility to antibiotics among Clostridioides difficile strains on disease severity: a single-center study. Antimicrob. Agents Chemother. 66, e0048922 (2022).
Wingen-Heimann, S. M. et al. Clostridioides difficile infection (CDI): a pan-European multi-center cost and resource utilization study, results from the combatting bacterial resistance in Europe CDI (COMBACTE-CDI). Clin. Microbiol. Infect. 29, e651–658 (2023).
Feuerstadt, P., Nelson, W. W., Teigland, C. & Dahdal, D. N. Clinical burden of recurrent Clostridioides difficile infection in the medicare population: a real-world claims analysis. Antimicrob. Steward. Healthc. Epidemiol. 2, e60 (2022).
Miles-Jay, A. et al. Longitudinal genomic surveillance of carriage and transmission of Clostridioides difficile in an intensive care unit. Nat. Med. 29, 2526–2534 (2023).
Eubank, T. A., Dureja, C., Garey, K. W., Hurdle, J. G. & Gonzales-Luna, A. J. Reduced vancomycin susceptibility in Clostridioides difficile is associated with lower rates of initial cure and sustained clinical response. Clin. Infect. Dis. 79, 15–21 (2024).
Gonzales-Luna, A. J. et al. Redefining Clostridioides difficile infection antibiotic response and clinical outcomes. Lancet Infect. Dis. 23, e259–e265 (2023).
Kociolek, L. K. et al. Strategies to prevent Clostridioides difficile infections in acute-care hospitals: 2022 update. Infect. Control Hosp. Epidemiol. 44, 527–549 (2023).
Warren, C. A. et al. Contribution of adenosine A(2B) receptors in Clostridium difficile intoxication and infection. Infect. Immun. 80, 4463–4473 (2012).
Chen, X. et al. A mouse model of Clostridium difficile-associated disease. Gastroenterology 135, 1984–1992 (2008).
Fletcher, J. R. et al. Clostridioides difficile exploits toxin-mediated inflammation to alter the host nutritional landscape and exclude competitors from the gut microbiota. Nat. Commun. 12, 462 (2021).
Carter, G. P. et al. Defining the roles of TcdA and TcdB in localized gastrointestinal disease, systemic organ damage, and the host response during Clostridium difficile infections. mBio 6, e00551 (2015).
Brito, G. A. et al. Clostridium difficile toxin A induces intestinal epithelial cell apoptosis and damage: role of Gln and Ala-Gln in toxin A effects. Dig. Dis. Sci. 50, 1271–1278 (2005).
D’Auria, K. M. et al. High temporal resolution of glucosyltransferase dependent and independent effects of Clostridium difficile toxins across multiple cell types. BMC Microbiol. 15, 7 (2015).
Brito, G. A. et al. Mechanism of Clostridium difficile toxin A-induced apoptosis in T84 cells. J. Infect. Dis. 186, 1438–1447 (2002).
Carneiro, B. A. et al. Caspase and bid involvement in Clostridium difficile toxin A-induced apoptosis and modulation of toxin A effects by glutamine and alanyl-glutamine in vivo and in vitro. Infect. Immun. 74, 81–87 (2006).
Foschetti, D. A. et al. Clostridium difficile toxins or infection induce upregulation of adenosine receptors and IL-6 with early pro-inflammatory and late anti-inflammatory pattern. Braz. J. Med. Biol. Res. 53, e9877 (2020).
Tian, S. et al. Identification of TFPI as a receptor reveals recombination-driven receptor switching in Clostridioides difficile toxin B variants. Nat. Commun. 13, 6786 (2022).
Chen, P. et al. Structural basis for recognition of frizzled proteins by Clostridium difficile toxin B. Science 360, 664–669 (2018).
Chen, P. et al. Structural basis for CSPG4 as a receptor for TcdB and a therapeutic target in Clostridioides difficile infection. Nat. Commun. 12, 3748 (2021).
Yuan, P. et al. Chondroitin sulfate proteoglycan 4 functions as the cellular receptor for Clostridium difficile toxin B. Cell Res. 25, 157–168 (2015).
LaFrance, M. E. et al. Identification of an epithelial cell receptor responsible for Clostridium difficile TcdB-induced cytotoxicity. Proc. Natl Acad. Sci. USA 112, 7073–7078 (2015).
Guo, S. et al. Low-density lipoprotein receptor-related protein 1 is a CROPs-associated receptor for Clostridioides infection toxin B. Sci. China Life Sci. 65, 107–118 (2022).
Tao, L. et al. Sulfated glycosaminoglycans and low-density lipoprotein receptor contribute to Clostridium difficile toxin A entry into cells. Nat. Microbiol. 4, 1760–1769 (2019).
Peritore-Galve, F. C. et al. Glucosyltransferase-dependent and independent effects of Clostridioides difficile toxins during infection. PLoS Pathog. 18, e1010323 (2022).
Jenior, M. L., Leslie, J. L., Young, V. B. & Schloss, P. D. Clostridium difficile alters the structure and metabolism of distinct cecal microbiomes during initial infection to promote sustained colonization. mSphere 3, e00261-18 (2018).
Aguirre, A. M. & Sorg, J. A. Gut associated metabolites and their roles in Clostridioides difficile pathogenesis. Gut Microbes 14, 2094672 (2022).
Schnizlein, M. K. & Young, V. B. Capturing the environment of the Clostridioides difficile infection cycle. Nat. Rev. Gastroenterol. Hepatol. 19, 508–520 (2022).
Ke, S. et al. Integrating gut microbiome and host immune markers to understand the pathogenesis of Clostridioides difficile infection. Gut Microbes 13, 1–18 (2021).
Barron, M. R. et al. Intestinal inflammation reversibly alters the microbiota to drive susceptibility to Clostridioides difficile colonization in a mouse model of colitis. mBio 13, e0190422 (2022).
Xu, Q. et al. The evaluation of fecal microbiota transplantation vs vancomycin in a Clostridioides difficile infection model. Appl. Microbiol. Biotechnol. 106, 6689–6700 (2022).
Martinez, E., Taminiau, B., Rodriguez, C. & Daube, G. Gut microbiota composition associated with Clostridioides difficile colonization and infection. Pathogens 11, 781 (2022).
Wu, Z. et al. Akkermansia muciniphila ameliorates Clostridioides difficile infection in mice by modulating the intestinal microbiome and metabolites. Front. Microbiol. 13, 841920 (2022).
Wu, Z. et al. The impact of dietary fibers on Clostridioides difficile infection in a mouse model. Front. Cell. Infect. Microbiol. 12, 1028267 (2022).
Dieterle, M. G. et al. Systemic inflammatory mediators are effective biomarkers for predicting adverse outcomes in Clostridioides difficile infection. mBio 11, e00180-20 (2020).
Abhyankar, M. M. et al. Immune profiling to predict outcome of Clostridioides difficile infection. mBio 11, e00905–e00920 (2020).
Zhang, T. et al. Clostridium difficile infection worsen outcome of hospitalized patients with inflammatory bowel disease. Sci. Rep. 6, 29791 (2016).
Chen, X. L. et al. High incidence and morbidity of Clostridium difficile infection among hospitalized patients with inflammatory bowel disease: a prospective observational cohort study. J. Dig. Dis. 20, 460–466 (2019).
Barber, G. E., Hendler, S., Okafor, P., Limsui, D. & Limketkai, B. N. Rising incidence of intestinal infections in inflammatory bowel disease: a nationwide analysis. Inflamm. Bowel Dis. 24, 1849–1856 (2018).
Dalal, R. S., Mitri, J., Goodrick, H. & Allegretti, J. R. Risk of gastrointestinal infections after initiating vedolizumab and anti-TNFα agents for ulcerative colitis. J. Clin. Gastroenterol. 57, 714–720 (2023).
Connelly, T. M. et al. An interleukin-4 polymorphism is associated with susceptibility to Clostridium difficile infection in patients with inflammatory bowel disease: results of a retrospective cohort study. Surgery 156, 769–774 (2014).
Kim, M. N. et al. Clostridium difficile infection aggravates colitis in interleukin 10-deficient mice. World J. Gastroenterol. 20, 17084–17091 (2014).
Saleh, M. M. et al. Colitis-induced Th17 cells increase the risk for severe subsequent Clostridium difficile infection. Cell Host Microbe 25, 756–765.e5 (2019).
Zhou, F. et al. Mice with inflammatory bowel disease are susceptible to Clostridium difficile infection with severe disease outcomes. Inflamm. Bowel Dis. 24, 573–582 (2018).
Zheng, M. et al. A single-cell map of peripheral alterations after FMT treatment in patients with systemic lupus erythematosus. J. Autoimmun. 135, 102989 (2023).
Littmann, E. R. et al. Host immunity modulates the efficacy of microbiota transplantation for treatment of Clostridioides difficile infection. Nat. Commun. 12, 755 (2021).
Graham, D. B. & Xavier, R. J. Conditioning of the immune system by the microbiome. Trends Immunol. 44, 499–511 (2023).
Jordan, C. K. I. & Clarke, T. B. How does the microbiota control systemic innate immunity? Trends Immunol. 45, 94–102 (2024).
Spindler, M. P. et al. Human gut microbiota stimulate defined innate immune responses that vary from phylum to strain. Cell Host Microbe 30, 1481–1498.e5 (2022).
Obata, Y. et al. Neuronal programming by microbiota regulates intestinal physiology. Nature 578, 284–289 (2020).
Vicentini, F. A. et al. Intestinal microbiota shapes gut physiology and regulates enteric neurons and glia. Microbiome 9, 210 (2021).
De Vadder, F. et al. Gut microbiota regulates maturation of the adult enteric nervous system via enteric serotonin networks. Proc. Natl Acad. Sci. USA 115, 6458–6463 (2018).
Seguella, L., Palenca, I., Franzin, S. B., Zilli, A. & Esposito, G. Mini-review: interaction between intestinal microbes and enteric glia in health and disease. Neurosci. Lett. 806, 137221 (2023).
Yarandi, S. S. et al. Intestinal bacteria maintain adult enteric nervous system and nitrergic neurons via Toll-like receptor 2-induced neurogenesis in mice. Gastroenterology 159, 200–213.e8 (2020).
Yan, Y. et al. Interleukin-6 produced by enteric neurons regulates the number and phenotype of microbe-responsive regulatory T cells in the gut. Immunity 54, 499–513.e5 (2021).
Chen, K., Magri, G., Grasset, E. K. & Cerutti, A. Rethinking mucosal antibody responses: IgM, IgG and IgD join IgA. Nat. Rev. Immunol. 20, 427–441 (2020).
Ouyang, W. & O’Garra, A. IL-10 family cytokines IL-10 and IL-22: from basic science to clinical translation. Immunity 50, 871–891 (2019).
Yu, H. et al. Cytokines are markers of the Clostridium difficile-induced inflammatory response and predict disease severity. Clin. Vaccin. Immunol. 24, e00037-17 (2017).
Hamo, Z., Azrad, M., Nitzan, O. & Peretz, A. Characterization of the immune response during infection caused by Clostridioides difficile. Microorganisms 7, 435 (2019).
Frisbee, A. L. et al. IL-33 drives group 2 innate lymphoid cell-mediated protection during Clostridium difficile infection. Nat. Commun. 10, 2712 (2019).
Peniche, A. G., Spinler, J. K., Boonma, P., Savidge, T. C. & Dann, S. M. Aging impairs protective host defenses against Clostridioides (Clostridium) difficile infection in mice by suppressing neutrophil and IL-22 mediated immunity. Anaerobe 54, 83–91 (2018).
Nagao-Kitamoto, H. et al. Interleukin-22-mediated host glycosylation prevents Clostridioides difficile infection by modulating the metabolic activity of the gut microbiota. Nat. Med. 26, 608–617 (2020).
Zackular, J. P. et al. Dietary zinc alters the microbiota and decreases resistance to Clostridium difficile infection. Nat. Med. 22, 1330–1334 (2016).
Donlan, A. N., Simpson, M. E. & Petri, W. A. Jr. Type 2 cytokines IL-4 and IL-5 reduce severe outcomes from Clostridiodes difficile infection. Anaerobe 66, 102275 (2020).
Wang, L., Cao, J., Li, C. & Zhang, L. IL-27/IL-27 receptor signaling provides protection in Clostridium difficile-induced colitis. J. Infect. Dis. 217, 198–207 (2018).
Buonomo, E. L. et al. Microbiota-regulated IL-25 increases eosinophil number to provide protection during Clostridium difficile infection. Cell Rep. 16, 432–443 (2016).
Secca, C. et al. Spatial distribution of LTi-like cells in intestinal mucosa regulates type 3 innate immunity. Proc. Natl Acad. Sci. USA 118, e2101668118 (2021).
Xu, B., Wu, X., Gong, Y. & Cao, J. IL-27 induces LL-37/CRAMP expression from intestinal epithelial cells: implications for immunotherapy of Clostridioides difficile infection. Gut Microbes 13, 1968258 (2021).
Hasegawa, M. et al. Interleukin-22 regulates the complement system to promote resistance against pathobionts after pathogen-induced intestinal damage. Immunity 41, 620–632 (2014).
Buonomo, E. L. et al. Role of interleukin 23 signaling in Clostridium difficile colitis. J. Infect. Dis. 208, 917–920 (2013).
McDermott, A. J. et al. Interleukin-23 (IL-23), independent of IL-17 and IL-22, drives neutrophil recruitment and innate inflammation during Clostridium difficile colitis in mice. Immunology 147, 114–124 (2016).
Wang, J. et al. Therapeutic mechanism of macrophage inflammatory protein 1α neutralizing antibody (CCL3) in Clostridium difficile infection in mice. J. Infect. Dis. 221, 1623–1635 (2020).
Nakagawa, T. et al. Endogenous IL-17 as a factor determining the severity of Clostridium difficile infection in mice. J. Med. Microbiol. 65, 821–827 (2016).
Ryan, A. et al. A role for TLR4 in Clostridium difficile infection and the recognition of surface layer proteins. PLoS Pathog. 7, e1002076 (2011).
Jarchum, I., Liu, M., Shi, C., Equinda, M. & Pamer, E. G. Critical role for MyD88-mediated neutrophil recruitment during Clostridium difficile colitis. Infect. Immun. 80, 2989–2996 (2012).
Viladomiu, M. et al. Modeling the role of peroxisome proliferator-activated receptor γ and microRNA-146 in mucosal immune responses to Clostridium difficile. PLoS ONE 7, e47525 (2012).
Spencer, N. J. & Hu, H. Enteric nervous system: sensory transduction, neural circuits and gastrointestinal motility. Nat. Rev. Gastroenterol. Hepatol. 17, 338–351 (2020).
Sharkey, K. A. & Mawe, G. M. The enteric nervous system. Physiol. Rev. 103, 1487–1564 (2023).
Gershon, M. D. & Margolis, K. G. The gut, its microbiome, and the brain: connections and communications. J. Clin. Invest. 131, e143768 (2021).
Prescott, S. L. & Liberles, S. D. Internal senses of the vagus nerve. Neuron 110, 579–599 (2022).
Meregnani, J. et al. Anti-inflammatory effect of vagus nerve stimulation in a rat model of inflammatory bowel disease. Auton. Neurosci. 160, 82–89 (2011).
Matheis, F. et al. Adrenergic signaling in muscularis macrophages limits infection-induced neuronal loss. Cell 180, 64–78.e16 (2020).
Grubisic, V. et al. Enteric glia modulate macrophage phenotype and visceral sensitivity following inflammation. Cell Rep. 32, 108100 (2020).
Viola, M. F. et al. Dedicated macrophages organize and maintain the enteric nervous system. Nature 618, 818–826 (2023).
Jarret, A. et al. Enteric nervous system-derived IL-18 orchestrates mucosal barrier immunity. Cell 180, 813–814 (2020).
Drokhlyansky, E. et al. The human and mouse enteric nervous system at single-cell resolution. Cell 182, 1606–1622.e23 (2020).
Martins, C. S. et al. Clostridioides difficile toxin A-induced Wnt/β-catenin pathway inhibition is mediated by Rac1 glucosylation. Front. Microbiol. 11, 1998 (2020).
Fettucciari, K. et al. Enteric glial cells are susceptible to Clostridium difficile toxin B. Cell. Mol. Life Sci. 74, 1527–1551 (2017).
David, M., Petit, D. & Bertoglio, J. Cell cycle regulation of Rho signaling pathways. Cell Cycle 11, 3003–3010 (2012).
Zhang, B., Zhang, Y. & Shacter, E. Caspase 3-mediated inactivation of rac GTPases promotes drug-induced apoptosis in human lymphoma cells. Mol. Cell. Biol. 23, 5716–5725 (2003).
Schurmann, A. et al. p21-activated kinase 1 phosphorylates the death agonist bad and protects cells from apoptosis. Mol. Cell. Biol. 20, 453–461 (2000).
Murga, C., Zohar, M., Teramoto, H. & Gutkind, J. S. Rac1 and RhoG promote cell survival by the activation of PI3K and Akt, independently of their ability to stimulate JNK and NF-kappaB. Oncogene 21, 207–216 (2002).
Delvalle, N. M. et al. Communication between enteric neurons, glia, and nociceptors underlies the effects of tachykinins on neuroinflammation. Cell. Mol. Gastroenterol. Hepatol. 6, 321–344 (2018).
Fettucciari, K. et al. Clostridioides difficile toxin B alone and with pro-inflammatory cytokines induces apoptosis in enteric glial cells by activating three different signalling pathways mediated by caspases, calpains and cathepsin B. Cell. Mol. Life Sci. 79, 442 (2022).
Talukdar, R. et al. Release of cathepsin B in cytosol causes cell death in acute pancreatitis. Gastroenterology 151, 747–758.e5 (2016).
Xie, Z. et al. Cathepsin B in programmed cell death machinery: mechanisms of execution and regulatory pathways. Cell Death Dis. 14, 255 (2023).
Shi, H. et al. Inhibition of calpain reduces cell apoptosis by suppressing mitochondrial fission in acute viral myocarditis. Cell Biol. Toxicol. 38, 487–504 (2022).
Momeni, H. R. Role of calpain in apoptosis. Cell J. 13, 65–72 (2011).
Houde, C. et al. Caspase-7 expanded function and intrinsic expression level underlies strain-specific brain phenotype of caspase-3-null mice. J. Neurosci. 24, 9977–9984 (2004).
Janicke, R. U., Sprengart, M. L., Wati, M. R. & Porter, A. G. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 273, 9357–9360 (1998).
Singh, R., Letai, A. & Sarosiek, K. Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins. Nat. Rev. Mol. Cell Biol. 20, 175–193 (2019).
McIlwain, D. R., Berger, T. & Mak, T. W. Caspase functions in cell death and disease. Cold Spring Harb. Perspect. Biol. 5, a008656 (2013).
Abt, M. C. et al. Innate immune defenses mediated by two ILC subsets are critical for protection against acute Clostridium difficile infection. Cell Host Microbe 18, 27–37 (2015).
Progatzky, F. et al. Regulation of intestinal immunity and tissue repair by enteric glia. Nature 599, 125–130 (2021).
Macchioni, L. et al. Enteric glial cells counteract Clostridium difficile toxin B through a NADPH oxidase/ROS/JNK/caspase-3 axis, without involving mitochondrial pathways. Sci. Rep. 7, 45569 (2017).
Jiang, Y. et al. NOX4 inhibition protects enteric glial cells against Clostridium difficile toxin B toxicity via attenuating oxidative and endoplasmic reticulum stresses. Free Radic. Res. 53, 932–940 (2019).
Yoon, I. N., Hwang, J. S., Lee, J. H. & Kim, H. The antimicrobial peptide CopA3 inhibits Clostridium difficile toxin A-induced viability loss and apoptosis in neural cells. J. Microbiol. Biotechnol. 29, 30–36 (2019).
Sies, H. & Jones, D. P. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat. Rev. Mol. Cell Biol. 21, 363–383 (2020).
Zhang, P. et al. Clostridium difficile toxin A induces reactive oxygen species production and p38 MAPK activation to exert cellular toxicity in neuronal cells. J. Microbiol. Biotechnol. 27, 1163–1170 (2017).
Brown, I. A., McClain, J. L., Watson, R. E., Patel, B. A. & Gulbransen, B. D. Enteric glia mediate neuron death in colitis through purinergic pathways that require connexin-43 and nitric oxide. Cell. Mol. Gastroenterol. Hepatol. 2, 77–91 (2016).
Brown, I. A. M. & Gulbransen, B. D. The antioxidant glutathione protects against enteric neuron death in situ, but its depletion is protective during colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 314, G39–G52 (2018).
Loureiro, A. V. et al. Role of pannexin-1-P2X7R signaling on cell death and pro-inflammatory mediator expression induced by Clostridioides difficile toxins in enteric glia. Front. Immunol. 13, 956340 (2022).
Grassi, F. & Marino, R. The P2X7 receptor in mucosal adaptive immunity. Purinergic Signal. 20, 9–19 (2024).
Gulbransen, B. D. et al. Activation of neuronal P2X7 receptor-pannexin-1 mediates death of enteric neurons during colitis. Nat. Med. 18, 600–604 (2012).
Burnstock, G. Purinergic signalling: from discovery to current developments. Exp. Physiol. 99, 16–34 (2014).
Burnstock, G. Purinergic signalling in the gastrointestinal tract and related organs in health and disease. Purinergic Signal. 10, 3–50 (2014).
Grubisic, V. et al. NTPDase1 and -2 are expressed by distinct cellular compartments in the mouse colon and differentially impact colonic physiology and function after DSS colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 317, G314–G332 (2019).
Antonioli, L., Pacher, P., Vizi, E. S. & Hasko, G. CD39 and CD73 in immunity and inflammation. Trends Mol. Med. 19, 355–367 (2013).
Grubisic, V. et al. Enteric glial adenosine 2B receptor signaling mediates persistent epithelial barrier dysfunction following acute DSS colitis. Mucosal Immunol. 15, 964–976 (2022).
Costa, D. V. S. et al. 5-Fluorouracil induces enteric neuron death and glial activation during intestinal mucositis via a S100B-RAGE-NFκB-dependent pathway. Sci. Rep. 9, 665 (2019).
Zhang, X. S. et al. Activation of the RAGE/STAT3 pathway in the dorsal root ganglion contributes to the persistent pain hypersensitivity induced by lumbar disc herniation. Pain Physician 20, 419–427 (2017).
Moysa, A. et al. A model of full-length RAGE in complex with S100B. Structure 29, 989–1002.e6 (2021).
Zhang, H. et al. Toll-like receptor 4 (TLR4) expression affects Schwann cell behavior in vitro. Sci. Rep. 8, 11179 (2018).
Gabanyi, I. et al. Neuro-immune interactions drive tissue programming in intestinal macrophages. Cell 164, 378–391 (2016).
Nasser, Y., Ho, W. & Sharkey, K. A. Distribution of adrenergic receptors in the enteric nervous system of the guinea pig, mouse, and rat. J. Comp. Neurol. 495, 529–553 (2006).
Wang, P. et al. Adrenergic nerves regulate intestinal regeneration through IL-22 signaling from type 3 innate lymphoid cells. Cell Stem Cell 30, 1166–1178.e8 (2023).
Ten Hove, A. S. et al. Sympathetic activity regulates epithelial proliferation and wound healing via adrenergic receptor α2A. Sci. Rep. 13, 17990 (2023).
Li, C. et al. Enterococcus-derived tyramine hijacks α2A-adrenergic receptor in intestinal stem cells to exacerbate colitis. Cell Host Microbe 32, 950–963.e8 (2024).
Tyus, D. et al. The sympathetic nervous system drives hyperinflammatory responses to Clostridioides difficile infection. Cell Rep. Med. 5, 101771 (2024).
Neunlist, M. et al. Toxin B of Clostridium difficile activates human VIP submucosal neurons, in part via an IL-1beta-dependent pathway. Am. J. Physiol. Gastrointest. Liver Physiol. 285, G1049–G1055 (2003).
Tixier, E., Lalanne, F., Just, I., Galmiche, J. P. & Neunlist, M. Human mucosa/submucosa interactions during intestinal inflammation: involvement of the enteric nervous system in interleukin-8 secretion. Cell Microbiol. 7, 1798–1810 (2005).
Schiller, M. et al. Optogenetic activation of local colonic sympathetic innervations attenuates colitis by limiting immune cell extravasation. Immunity 54, 1022–1036.e8 (2021).
Ahrends, T. et al. Enteric pathogens induce tissue tolerance and prevent neuronal loss from subsequent infections. Cell 184, 5715–5727.e12 (2021).
Mantyh, C. R. et al. Substance P activation of enteric neurons in response to intraluminal Clostridium difficile toxin A in the rat ileum. Gastroenterology 111, 1272–1280 (1996).
Pothoulakis, C. et al. Substance P receptor expression in intestinal epithelium in Clostridium difficile toxin A enteritis in rats. Am. J. Physiol. 275, G68–G75 (1998).
Castagliuolo, I. et al. Neuronal involvement in the intestinal effects of Clostridium difficile toxin A and Vibrio cholerae enterotoxin in rat ileum. Gastroenterology 107, 657–665 (1994).
Castagliuolo, I. et al. Neurokinin-1 (NK-1) receptor is required in Clostridium difficile-induced enteritis. J. Clin. Invest. 101, 1547–1550 (1998).
McVey, D. C. & Vigna, S. R. The capsaicin VR1 receptor mediates substance P release in toxin A-induced enteritis in rats. Peptides 22, 1439–1446 (2001).
Matsumoto, K. et al. Localization of TRPV1 and contractile effect of capsaicin in mouse large intestine: high abundance and sensitivity in rectum and distal colon. Am. J. Physiol. Gastrointest. Liver Physiol. 297, G348–G360 (2009).
Anton, P. M. et al. Corticotropin-releasing hormone (CRH) requirement in Clostridium difficile toxin A-mediated intestinal inflammation. Proc. Natl Acad. Sci. USA 101, 8503–8508 (2004).
Morelli, A. E. et al. Neurokinin-1 receptor signaling is required for efficient Ca2+ flux in T-cell-receptor-activated T cells. Cell Rep. 30, 3448–3465.e8 (2020).
Ge, C. et al. Neurokinin-1 receptor is an effective target for treating leukemia by inducing oxidative stress through mitochondrial calcium overload. Proc. Natl Acad. Sci. USA 116, 19635–19645 (2019).
Bhargava, A. et al. Local injection of dsRNA targeting calcitonin receptor-like receptor (CLR) ameliorates Clostridium difficile toxin A-induced ileitis. Proc. Natl Acad. Sci. USA 110, 731–736 (2013).
McCoy, E. S. et al. Peptidergic CGRPα primary sensory neurons encode heat and itch and tonically suppress sensitivity to cold. Neuron 78, 138–151 (2013).
Russell, F. A., King, R., Smillie, S. J., Kodji, X. & Brain, S. D. Calcitonin gene-related peptide: physiology and pathophysiology. Physiol. Rev. 94, 1099–1142 (2014).
Zoumboulakis, D., Cirella, K. R., Gougeon, P. Y., Lourenssen, S. R. & Blennerhassett, M. G. MMP-9 processing of intestinal smooth muscle-derived GDNF is required for neurotrophic action on enteric neurons. Neuroscience 443, 8–18 (2020).
Rodrigues, D. M., Li, A. Y., Nair, D. G. & Blennerhassett, M. G. Glial cell line-derived neurotrophic factor is a key neurotrophin in the postnatal enteric nervous system. Neurogastroenterol. Motil. 23, e44–e56 (2011).
Han, T. Y., Lourenssen, S., Miller, K. G. & Blennerhassett, M. G. Intestinal smooth muscle phenotype determines enteric neuronal survival via GDNF expression. Neuroscience 290, 357–368 (2015).
Steinkamp, M. et al. GDNF protects enteric glia from apoptosis: evidence for an autocrine loop. BMC Gastroenterol. 12, 6 (2012).
McKeown, S. J., Mohsenipour, M., Bergner, A. J., Young, H. M. & Stamp, L. A. Exposure to GDNF enhances the ability of enteric neural progenitors to generate an enteric nervous system. Stem Cell Rep. 8, 476–488 (2017).
Soret, R. et al. Glial cell-derived neurotrophic factor induces enteric neurogenesis and improves colon structure and function in mouse models of Hirschsprung disease. Gastroenterology 159, 1824–1838.e17 (2020).
Belkind-Gerson, J. et al. Colitis promotes neuronal differentiation of Sox2+ and PLP1+ enteric cells. Sci. Rep. 7, 2525 (2017).
Wright, C. M. et al. scRNA-seq reveals new enteric nervous system roles for GDNF, NRTN, and TBX3. Cell. Mol. Gastroenterol. Hepatol. 11, 1548–1592.e1 (2021).
Meir, M. et al. Neurotrophic factor GDNF regulates intestinal barrier function in inflammatory bowel disease. J. Clin. Invest. 129, 2824–2840 (2019).
Xiao, W. et al. GDNF is involved in the barrier-inducing effect of enteric glial cells on intestinal epithelial cells under acute ischemia reperfusion stimulation. Mol. Neurobiol. 50, 274–289 (2014).
Chow, A. K., Grubisic, V. & Gulbransen, B. D. Enteric glia regulate lymphocyte activation via autophagy-mediated MHC-II expression. Cell. Mol. Gastroenterol. Hepatol. 12, 1215–1237 (2021).
Schneider, R. et al. IL-1-dependent enteric gliosis guides intestinal inflammation and dysmotility and modulates macrophage function. Commun. Biol. 5, 811 (2022).
Ibiza, S. et al. Glial-cell-derived neuroregulators control type 3 innate lymphoid cells and gut defence. Nature 535, 440–443 (2016).
Baghdadi, M. B. et al. Enteric glial cell heterogeneity regulates intestinal stem cell niches. Cell Stem Cell 29, 86–100.e6 (2022).
Puzan, M., Hosic, S., Ghio, C. & Koppes, A. Enteric nervous system regulation of intestinal stem cell differentiation and epithelial monolayer function. Sci. Rep. 8, 6313 (2018).
Wang, H., Foong, J. P. P., Harris, N. L. & Bornstein, J. C. Enteric neuroimmune interactions coordinate intestinal responses in health and disease. Mucosal Immunol. 15, 27–39 (2022).
Delvalle, N. M., Fried, D. E., Rivera-Lopez, G., Gaudette, L. & Gulbransen, B. D. Cholinergic activation of enteric glia is a physiological mechanism that contributes to the regulation of gastrointestinal motility. Am. J. Physiol. Gastrointest. Liver Physiol. 315, G473–G483 (2018).
Gulbransen, B. D. & Sharkey, K. A. Purinergic neuron-to-glia signaling in the enteric nervous system. Gastroenterology 136, 1349–1358 (2009).
Zhang, W., Segura, B. J., Lin, T. R., Hu, Y. & Mulholland, M. W. Intercellular calcium waves in cultured enteric glia from neonatal guinea pig. Glia 42, 252–262 (2003).
Kimball, B. C. & Mulholland, M. W. Enteric glia exhibit P2U receptors that increase cytosolic calcium by a phospholipase C-dependent mechanism. J. Neurochem. 66, 604–612 (1996).
Turco, F. et al. Enteroglial-derived S100B protein integrates bacteria-induced Toll-like receptor signalling in human enteric glial cells. Gut 63, 105–115 (2014).
Barajon, I. et al. Toll-like receptors 3, 4, and 7 are expressed in the enteric nervous system and dorsal root ganglia. J. Histochem. Cytochem. 57, 1013–1023 (2009).
Brun, P. et al. Toll-like receptor 2 regulates intestinal inflammation by controlling integrity of the enteric nervous system. Gastroenterology 145, 1323–1333 (2013).
Baidoo, N., Sanger, G. J. & Belai, A. Effect of old age on the subpopulations of enteric glial cells in human descending colon. Glia 71, 305–316 (2023).
Ferri, G. L. et al. Evidence for the presence of S-100 protein in the glial component of the human enteric nervous system. Nature 297, 409–410 (1982).
Seguella, L. & Gulbransen, B. D. Enteric glial biology, intercellular signalling and roles in gastrointestinal disease. Nat. Rev. Gastroenterol. Hepatol. 18, 571–587 (2021).
Ahmadzai, M. M., Seguella, L. & Gulbransen, B. D. Circuit-specific enteric glia regulate intestinal motor neurocircuits. Proc. Natl Acad. Sci. USA 118, e2025938118 (2021).
Bauman, B. D. et al. Enteric glial-mediated enhancement of intestinal barrier integrity is compromised by morphine. J. Surg. Res. 219, 214–221 (2017).
Savidge, T. C. et al. Enteric glia regulate intestinal barrier function and inflammation via release of S-nitrosoglutathione. Gastroenterology 132, 1344–1358 (2007).
Kulkarni, S. et al. Adult enteric nervous system in health is maintained by a dynamic balance between neuronal apoptosis and neurogenesis. Proc. Natl Acad. Sci. USA 114, E3709–E3718 (2017).
Virtanen, H., Garton, D. R. & Andressoo, J. O. Myenteric neurons do not replicate in small intestine under normal physiological conditions in adult mouse. Cell. Mol. Gastroenterol. Hepatol. 14, 27–34 (2022).
Belkind-Gerson, J. et al. Colitis induces enteric neurogenesis through a 5-HT4-dependent mechanism. Inflamm. Bowel Dis. 21, 870–878 (2015).
Zhou, C. et al. Comprehensive profiling reveals mechanisms of SOX2-mediated cell fate specification in human ESCs and NPCs. Cell Res. 26, 171–189 (2016).
Guyer, R. A. et al. Single-cell multiome sequencing clarifies enteric glial diversity and identifies an intraganglionic population poised for neurogenesis. Cell Rep. 42, 112194 (2023).
Fettucciari, K. et al. Clostridium difficile toxin B induces senescence in enteric glial cells: a potential new mechanism of Clostridium difficile pathogenesis. Biochim. Biophys. Acta Mol. Cell Res. 1865, 1945–1958 (2018).
